Ukti N. Mani

Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases

Yihan Wang, Chester A. Metcalf, William C. Shakespeare et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 51 citations · Full text

Medicinal Chemistry, Sclerostin, Bone-targeted 2,6,9-Trisubstituted Purines +10

Structure-activity relationships of a novel class of Src SH2 inhibitors

John L. Buchanan, Chi B. Vu, Taylor Merry et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 38 citations · Full text

Molecular Docking, Biochemistry, Medicine +8

Design, Synthesis, and Progress toward Optimization of Potent Small Molecule Antagonists of CC Chemokine Receptor 8 (CCR8)

Shomir Ghosh, Amy Elder, Jianping Guo et al. · Journal of Medicinal Chemistry · 2006 · 37 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Ligand Ccl1 +13

Normal and Abnormal Heme Biosynthesis. 1. Synthesis and Metabolism of Di- and Monocarboxylic Porphyrinogens Related to Coproporphyrinogen-III and Harderoporphyrinogen:  A Model for the Active Site of Coproporphyrinogen Oxidase

Timothy D. Lash, Ukti N. Mani, Martin A. Drinan et al. · The Journal of Organic Chemistry · 1998 · 29 citations

Copro'gen Oxidase, Molecular Biology, Organic Chemistry +20

Bone-Targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analogues

Raji Sundaramoorthi, William C. Shakespeare, Terence P. Keenan et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 21 citations · Full text

Medicinal Chemistry, Medicine, Pyrazolopyrimidine Analogues +5